Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: NBTXR3 and Radiation Therapy for the Treatment of Inoperable Recurrent Non-small Cell Lung Cancer [Phase 1]
A Phase 1 clinical trial update evaluates NBTXR3 hafnium oxide nanoparticles in combination with radiation therapy for inoperable recurrent …
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer [Phase 2]
Phase 2 study evaluating tiragolumab plus atezolizumab with or without platinum chemotherapy in untreated locally advanced resectable non-sm…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Tunlametinib Combination Therapy in KRAS-Mutated Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial assessing tunlametinib in combination therapy for KRAS-mutated unresectable locally advanced or metastatic non-smal…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Understanding Non-small Cell Lung Cancer Patient Characteristics, Treatment Patterns and Outcomes
A completed AstraZeneca-sponsored clinical trial update examining patient characteristics, treatment patterns, and outcomes in non-small cel…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer Which Could Not Be Controlled
Results from a completed study evaluating lorlatinib in patients with non-small cell lung cancer that could not be controlled have been post…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Daratumumab in STK11 Mutated NSCLC [Phase 2]
A Phase 2 clinical trial evaluating daratumumab in non-small cell lung cancer with STK11/LKB1 mutations has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer [NA]
Clinical trial update describing a Mayo Clinic-sponsored study that evaluates a decision-support tool to improve shared decision-making for …
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases [Phase 1]
This phase 1 study assessed pembrolizumab in combination with stereotactic radiosurgery for patients with brain metastases from melanoma or …
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Study of AK119 and AK112 With or Without Chemotherapy for NSCLC Patients [Phase 1, Phase 2]
A Phase 1/2 trial evaluating AK119 and AK112 with or without chemotherapy for non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Pulmonary Magnetic Resonance-guided Online Adaptive Radiotherapy of Locally Advanced Non-Small Cell Lung Cancer [NA]
This clinical trial update describes a study of pulmonary MR-guided online adaptive radiotherapy for locally advanced non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Image-Guided, Intensity-Modulated Photon or Proton Beam Radiation Therapy in Treating Patients With Stage II-IIIB Non-small Cell Lung Cancer [Phase 1, Phase 2]
This ClinicalTrials.gov entry outlines a Phase 1/2 study evaluating image-guided, intensity-modulated photon or proton beam radiation therap…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) [Phase 2]
Phase 2 basket study evaluating entrectinib in solid tumors harboring NTRK1/2/3, ROS1, or ALK gene rearrangements; the study is listed as Ac…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Liquid Biopsy Genotyping Using Oncomine Precision Assay GX in Advanced NSCLC [NA]
A completed clinical trial evaluating liquid biopsy genotyping using the Oncomine Precision Assay GX in advanced Non-Small Cell Lung Cancer.
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Implementing Circulating Tumor DNA Analysis at Initial Diagnosis to Improve Management of Advanced NSCLC Patients [NA]
The trial has completed and evaluated circulating tumor DNA analysis at initial diagnosis to guide management in patients with advanced non-…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: QLS5132 Combination Therapy in Advanced Solid Tumors [Phase 1, Phase 2]
This update describes a Phase 1/2 study of QLS5132 combination therapy in multiple cancers, including gastric cancer, non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: An Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 adjuvant trial evaluating SMS001 (paclitaxel) for non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 trial comparing pralsetinib to standard of care as first-line therapy for advanced RET-fusion non-small cell lung cancer was termina…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway [Phase 1]
Phase 1 trial of DCC-3084 for MAPK-pathway driven advanced cancers has been terminated. The update notes the study status without presenting…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: A Study to Investigate Efficacy and Safety of Ceralasertib Plus Durvalumab in Participants Aged ≥ 18 Years With Advanced or Metastatic Non-small Cell Lung Cancer Whose Disease Progressed on or After Prior Anti-PD-(L)1 Therapy and Platinum-based Chemotherapy [Phase 2]
This clinical trial update describes a Phase 2 study evaluating the combination of Ceralasertib and Durvalumab in adults with advanced or me…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer [Phase 1]
A Phase 1 clinical trial evaluating STRO-004 in adults with refractory or recurrent metastatic cancer is currently recruiting, investigating…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Integrative Analysis of Tumor Microenvironment and Optimization of Immunotherapy Duration in NSCL Cancer Patients [Phase 2]
Phase 2 trial in Non-Small Cell Lung Cancer investigating tumor microenvironment and optimal duration of immunotherapy has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Observing Patients With Palliative Asymptomatic Centrally Located Advanced Non-small Cell Lung Carcinoma (NSCLC)
The document notes a completed observational clinical trial involving patients with palliative, asymptomatic, centrally located advanced non…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: A Study of SHR-1210 in Combination With Apatinib in Advanced Non-Small Cell Lung Cancer(NSCLC) [Phase 2]
A Phase 2 trial evaluating SHR-1210 in combination with apatinib in advanced non-small cell lung cancer has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid Tumors [EARLY_Phase 1]
Phase I clinical trial update for HLX37 evaluating safety, tolerability, and pharmacokinetics in advanced/metastatic solid tumors. The study…
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: A Trial of AK112 (PD-1/VEGF Bispecific Antibody) in Patients With NSCLC [Phase 1, Phase 2]
The trial update indicates completion of a Phase 1/2 study evaluating AK112, a PD-1/VEGF bispecific antibody, in patients with non-small cel…